Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST: Glycopyrronium vs Tiotropium in COPD
NCT01922271Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Aug 2013; status: completed.
02
Drugs
glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01922271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922271.